Ikarian Capital, LLC Anebulo Pharmaceuticals, Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 157,720 shares of ANEB stock, worth $173,492. This represents 0.03% of its overall portfolio holdings.
Number of Shares
157,720
Previous 157,720
-0.0%
Holding current value
$173,492
Previous $264,000
22.35%
% of portfolio
0.03%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding ANEB
# of Institutions
19Shares Held
22.6MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$17 Million18.74% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$3.34 Million0.18% of portfolio
-
Mangrove Partners New York, NY2.53MShares$2.78 Million0.52% of portfolio
-
Morgan Stanley New York, NY399KShares$439,1400.0% of portfolio
-
Lvw Advisors, LLC350KShares$384,5780.06% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $28.2M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...